Literature DB >> 2914343

Development of coronary heart disease in familial hypercholesterolemia.

H Mabuchi1, J Koizumi, M Shimizu, R Takeda.   

Abstract

We studied the development of coronary artery disease in 10 homozygous and 692 heterozygous patients with familial hypercholesterolemia. Seventy-five (22%) male heterozygotes and 35 (10%) female heterozygotes were affected by myocardial infarction, which was first noted in men in the 3rd decade of life and in women in the 4th decade of life. Thirty-eight (70%) out of the deceased 54 heterozygous patients died of coronary heart disease. The mean age at death was significantly less in male heterozygotes (54 years) than in female heterozygotes (69 years). Five homozygous and 105 male and 56 female heterozygous patients received coronary angiographic evaluation. The regression equations between age (X) and coronary stenosis index (Y) obtained by assigning score (0 to 5) to each of 15 coronary artery segments were Y = 1.57X - 20.43 (r = 0.956, p less than 0.05) in the homozygotes, Y = 0.52X - 9.11 (r = 0.438, p less than 0.001) in the male heterozygotes, and Y = 0.47X - 12.54 (r = 0.343, p less than 0.01) in the female heterozygotes. From these data, we can assume that coronary artery stenosis detectable by angiography will occur after 17 and 25 years of age in male and female heterozygotes, respectively, and the treatment of heterozygotes with lipid-lowering drugs can be delayed until late adolescence.

Entities:  

Mesh:

Year:  1989        PMID: 2914343     DOI: 10.1161/01.cir.79.2.225

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  35 in total

1.  Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention.

Authors:  Hideki Kitahara; Naoto Mori; Yuichi Saito; Takashi Nakayama; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2019-04-09       Impact factor: 2.037

2.  Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: characterization of a recently described index of vascular function.

Authors:  Jonathan R Spiro; Janet E Digby; Gopal Ghimire; Mark Mason; Andrew G Mitchell; Charles Ilsley; Ann Donald; Miles C D Dalby; Rajesh K Kharbanda
Journal:  Eur Heart J       Date:  2010-10-29       Impact factor: 29.983

3.  Differing relationship between hypercholesterolemia and a bicuspid aortic valve according to the presence of aortic valve stenosis or aortic valve regurgitation.

Authors:  Masahiro Endo; Akihiro Nabuchi; Hiroshi Okuyama; Yasushi Muto; Susumu Hiranuma; Takuya Miyazaki; Joji Hosokawa; Yoshihisa Enjoji; Yumi Shimura; Osamu Hashimoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-06-02

4.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 5.  Familial Hypercholesterolaemia Diagnosis and Management.

Authors:  Rodrigo Alonso; Leopoldo Perez de Isla; Ovidio Muñiz-Grijalvo; Jose Luis Diaz-Diaz; Pedro Mata
Journal:  Eur Cardiol       Date:  2018-08

6.  A novel approach to screening for familial hypercholesterolemia in a large public venue.

Authors:  Megan Campbell; Jessa Humanki; Heather Zierhut
Journal:  J Community Genet       Date:  2016-11-26

7.  Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance.

Authors:  I Yokoyama; K Yonekura; Y Inoue; K Ohtomo; R Nagai
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

8.  Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.

Authors:  Tuyen N Tran; Malathi G Kosaraju; Shiori Tamamizu-Kato; Olayemi Akintunde; Ying Zheng; John K Bielicki; Kent Pinkerton; Koji Uchida; Yuan Yu Lee; Vasanthy Narayanaswami
Journal:  Biochemistry       Date:  2014-01-08       Impact factor: 3.162

9.  Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred.

Authors:  Keiko Sato; Mitsuru Emi; Yoichi Ezura; Yuko Fujita; Daisuke Takada; Tomoaki Ishigami; Satoshi Umemura; Yunpei Xin; Lily L Wu; Stacey Larrinaga-Shum; Susan H Stephenson; Steven C Hunt; Paul N Hopkins
Journal:  J Hum Genet       Date:  2003-12-13       Impact factor: 3.172

Review 10.  Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention.

Authors:  A van der Graaf; J J P Kastelein; A Wiegman
Journal:  J Inherit Metab Dis       Date:  2009-10-31       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.